DDX60 and neoplasm: Overall, a higher DDX60 expression was observed in OSCC patients with male gender (p= 0.002), low-grade cell differentiation (p= 0.004), advanced pathological stage (p= 0.023), and large tumor size (T3-T4, p= 0.001).